
Aegis Life Awarded Grant to Develop DNA-encoded Antibodies Against Infectious Diseases
SAN DIEGO, Calif. & EDMONTON, Alberta–(BUSINESS WIRE)–Aegis Life, Inc. (Aegis), and its parent company Entos Pharmaceuticals (Entos), a clinical-stage biotechnology company developing genetic medicines with its Fusogenix PLV delivery platform, today announced entering into a […]